Blood biomarkers predicting adverse clinical outcomes in congenital heart disease patients, with consideration for pulmonary valve replacement

Data publikacji: 29 mar 2023

Zakres stron: 11 - 16

Otrzymano: 20 paź 2022

Przyjęty: 14 lut 2023

DOI: https://doi.org/10.2478/amma-2023-0009

Słowa kluczowe

congenital heart disease, tetralogy of Fallot, pentalogy of Fallot, blood biomarkers, pulmonary valve replacement

© 2023 Milla Marika Kainlauri et al., published by Sciendo

This work is licensed under the Creative Commons Attribution 4.0 International License.